MIRA Pharmaceuticals, Inc. (MIRA)Healthcare | Drug Manufacturers - General | Miami, United States | NasdaqCM
1.06 USD
+0.01
(0.952%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 1.10 +0.04 (3.406%) ⇧ (April 17, 2026, 7:54 p.m. EDT) Short-term: ★★☆☆☆ | Long-term: ★☆☆☆☆ | Dividends: ☆☆☆☆☆ |
Hot Take | April 11, 2026, 1:19 p.m. EDT
MIRA Pharmaceuticals, Inc. (MIRA) has shown significant recent news momentum with positive preclinical data and breakthrough pain drug research, which could drive short-term price movement. However, the stock has been volatile and is currently trading below its 52-week low, with negative earnings and poor fundamentals. The short-term forecast indicates a slight upward trend, but the high beta and negative forward P/E suggest high risk. For long-term investment, the stock's fundamentals are weak, with negative returns on assets and equity, making it a risky proposition. There are no dividends, so it's not suitable for dividend-focused investors. |
| Model | MAE |
|---|---|
| MSTL ✓ | 0.201936 |
| AutoARIMA | 0.207347 |
| AutoETS | 0.207353 |
| AutoTheta | 0.207903 |
Forecast horizon: 45 days | Selected: MSTL
| Forecast Reliability | |
|---|---|
| Score | 51% |
| H-stat | 3.78 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.835 |
| Excess Kurtosis | -0.32 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 5.513 |
| Market Cap | 44,543,412 |
| Forward P/E | -2.59 |
| Beta | 1.94 |
| Website | https://mirapharmaceuticals.com |
| Attribute | Value |
|---|---|
| 52 Week Change | 0.22543347 |
| Address1 | 1,200 Brickell Avenue |
| Address2 | Suite 1950 #1183 |
| All Time High | 7.98 |
| All Time Low | 0.51 |
| Ask | 1.09 |
| Ask Size | 1 |
| Average Daily Volume10 Day | 117,910 |
| Average Daily Volume3 Month | 160,362 |
| Average Volume | 160,362 |
| Average Volume10Days | 117,910 |
| Beta | 1.936 |
| Bid | 1.06 |
| Bid Size | 1 |
| Book Value | 0.248 |
| City | Miami |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.06 |
| Current Ratio | 15.751 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 1.091 |
| Day Low | 1.046 |
| Debt To Equity | 5.513 |
| Display Name | MIRA Pharmaceuticals |
| Ebitda Margins | 0.0 |
| Enterprise Value | 34,086,256 |
| Eps Forward | -0.41 |
| Eps Trailing Twelve Months | -1.35 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.1394 |
| Fifty Day Average Change | -0.07940006 |
| Fifty Day Average Change Percent | -0.069685854 |
| Fifty Two Week Change Percent | 22.543346 |
| Fifty Two Week High | 2.45 |
| Fifty Two Week High Change | -1.3900001 |
| Fifty Two Week High Change Percent | -0.567347 |
| Fifty Two Week Low | 0.84 |
| Fifty Two Week Low Change | 0.21999997 |
| Fifty Two Week Low Change Percent | 0.26190475 |
| Fifty Two Week Range | 0.84 - 2.45 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,691,069,400,000 |
| Float Shares | 35,027,931 |
| Forward Eps | -0.41 |
| Forward P E | -2.5853658 |
| Free Cashflow | -812,591 |
| Full Exchange Name | NasdaqCM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.16595 |
| Held Percent Institutions | 0.0594 |
| Implied Shares Outstanding | 42,022,087 |
| Industry | Drug Manufacturers - General |
| Industry Disp | Drug Manufacturers - General |
| Industry Key | drug-manufacturers-general |
| Ipo Expected Date | 2,023-08-03 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | MIRA Pharmaceuticals, Inc. operates as a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a range of neurologic and neuropsychiatric disorders. The company holds exclusive U.S., Canadian, and Mexican rights for Ketamir-2, a patent pending oral ketamine analog under investigation to deliver ultra-rapid antidepressant effects for individuals battling treatment-resistant depression, major depressive disorder with suicidal ideation, and post-traumatic stress disorder. In addition, its oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia. The company was formerly known as MIRA1a Therapeutics, Inc. MIRA Pharmaceuticals, Inc. was incorporated in 2020 and is based in Miami, Florida. |
| Long Name | MIRA Pharmaceuticals, Inc. |
| Market | us_market |
| Market Cap | 44,543,412 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_1793899557 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -31,999,306 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 44,753,522 |
| Open | 1.05 |
| Operating Cashflow | -4,661,669 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 786 432 9792 |
| Post Market Change | 0.03610003 |
| Post Market Change Percent | 3.4056635 |
| Post Market Price | 1.0961 |
| Post Market Time | 1,776,470,057 |
| Previous Close | 1.05 |
| Price Hint | 4 |
| Price To Book | 4.2741933 |
| Profit Margins | 0.0 |
| Quick Ratio | 15.711 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.00999999 |
| Regular Market Change Percent | 0.95238 |
| Regular Market Day High | 1.091 |
| Regular Market Day Low | 1.046 |
| Regular Market Day Range | 1.046 - 1.091 |
| Regular Market Open | 1.05 |
| Regular Market Previous Close | 1.05 |
| Regular Market Price | 1.06 |
| Regular Market Time | 1,776,456,001 |
| Regular Market Volume | 128,159 |
| Return On Assets | -0.93577003 |
| Return On Equity | -1.65868 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 42,022,087 |
| Shares Percent Shares Out | 0.0104 |
| Shares Short | 437,032 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 489,206 |
| Short Name | MIRA Pharmaceuticals, Inc. |
| Short Percent Of Float | 0.0113 |
| Short Ratio | 2.45 |
| Source Interval | 15 |
| State | FL |
| Symbol | MIRA |
| Total Cash | 11,030,020 |
| Total Cash Per Share | 0.262 |
| Total Debt | 572,865 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.35 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 1.373675 |
| Two Hundred Day Average Change | -0.31367505 |
| Two Hundred Day Average Change Percent | -0.22834735 |
| Type Disp | Equity |
| Volume | 128,159 |
| Website | https://mirapharmaceuticals.com |
| Zip | 32,183 |